Umsawasdi, T <br/><br/>
Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Mar 1985 
 - 511-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/0360-3016(85)90182-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Squamous Cell--drug therapy<br/>Combined Modality Therapy<br/>Cyclophosphamide--adverse effects<br/>Doxorubicin--adverse effects<br/>Esophageal Diseases--etiology<br/>Esophageal Fistula--etiology<br/>Esophageal Stenosis--etiology<br/>Esophagitis--etiology<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Peptichemio--adverse effects<br/>Radiotherapy--adverse effects